课题基金 / 基金详情

Effects of exogenous endocrine-disrupters on the brain regions related to sexual differentiation and aggressive behavior

Effects of exogenous endocrine-disrupters on the brain regions related to sexual differentiation and aggressive behavior
外源性内分泌干扰物对与性别分化和攻击行为相关的大脑区域的影响
批准号:
12836010
负责人:
SHINODA Koh
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SHINODA Koh的其他基金

相似基金

相关文献

中文摘要
翻译
内源性性激素和外源性烷基酚类化合物对大鼠内视前核(MPN)、终纹床核主核(prBST)、内侧杏仁核(pdMAmg)后鼻侧部分颅内雌激素和雄激素受体(EsR和AnR)表达的影响进行了免疫组织化学研究,这些受体被认为与性功能和攻击行为有关。对去势大鼠分别注射车辆油(对照)、17β-雌二醇(E2)、二氢睾酮(DHT)、睾酮(T)、壬基酚(NP)和对叔辛基酚(OP),计数esr和anr的数量。在对照组中,脑内esr的表达被强烈增强,而anr的表达在几乎所有脑区几乎完全被抑制。大剂量E2 (100 ~ 250 μg/100g,连续1周)可使大鼠prBST和pdmag中EsR数量显著减少,AnR数量适度增加,MPN的增加较少,增加较多,减少。给予DHT (100 ~ 250 μg/100g 1周)后,3个区域的AnR显著增加,EsR数量略有减少。低剂量T (100 ~ 250 μg/100g,持续1周)导致prBST和pdMAmg的EsR数量明显减少,MPN的减少幅度较小,但AnR的增加没有成功。高剂量T (1mg/100g,连续1周)显著增加了AnR的数量,并显著降低了EsR的数量,AnR的数量在三个区域均有适度增加。与低剂量E2 (10 ~ 25 μg/100g,连续3天)组相比,NP (40mg/100g,连续3天)或OP (40mg/100g,连续3天)组在大鼠脑内三个脑区均表现出雌激素性EsR下调的作用,导致prBST和pdmag中EsR数量适度减少,MPN减少较少。综上所述,本研究强烈提示,内源性性激素和外源性烷基酚类化合物除了直接作用于两种受体外,还通过上调或下调颅内EsR或AnR的表达来影响脑组织的组织和激活。因此,NP或OP等内分泌干扰物可能通过其对MPN、prBST和pdMAmg中EsR的雌激素下调作用,干扰性别分化和对性功能和攻击行为的调节。少
英文摘要
Effects of endogenous sex-hormones and exogenous alkylphenolic compounds on expression of intracranial estrogen- and androgen-receptor (EsR and AnR) have immunohistochemically been evaluated in the rat medial preoptic nucleus (MPN), principal nucleus of the bed nucleus of the stria terminalis (prBST), posterodorsal part of the medial amygdaloid nucleus (pdMAmg), which have been considered to be related to sexual functions and aggressive behavior. Numbers of the EsRs and AnRs were counted in castrated rats which were injected vehicle-oil (control), 17β-estradiol (E2), dihydrotestosterone (DHT), testosterone (T), nonylphenol (NP) or p-tert-octylphenol (OP). In controls, expression of brain EsRs was strongly enhanced, while that of AnRs was almost completely suppressed in almost all brain regions. Administration of higher dose of E2 (100〜250 μg/100g for 1 week) resulted in prominent decrease of the number of EsR and moderate increase of that of AnR in the prBST and pdMAmg and less increas … More e and decrease in the MPN. Administration of DHT (100〜250 μg/100g 1 week) resulted in prominent increase of that of AnR and slight decrease of the number of EsR in all three regions. Administration of lower dose of T (100〜250 μg/100g for 1 week) resulted in prominent decrease of the number of EsR specifically in the prBST and pdMAmg and far less decrease in the MPN, but not successfully increase that of AnR, in any of the three regions. Administration of higher dose of T (1mg/100g for 1 week) prominently increased the number of the AnR in addition to prominent decrease of EsR have and moderate increase of that of AnR in all three regions. Injection of NP (40mg/100g for 3 days) or OP (40mg/100g for 3 days) was found to show estrogenic EsR-down regulation effects in all three brain regions as seen in the case of administration of lower dose of E2 (10〜25 μg/100g for 3 days), which resulted in moderate decrease of the number of EsR in the prBST and pdMAmg and less decrease in the MPN. Taken together, the present study strongly suggested that endogenous sex-hormone and exogenous alkylphenolic compounds effect on brain sexual organization and activation through up- or down-regulation of intracranial EsR or AnR expression in addition to direct actions on the two receptors. Thus it might be possible that endocrine-disrupters such as NP or OP can interfere sexual differentiation and regulation of the sexual functions and aggressive behavior through their estrogenic down-regulation effects on EsR in the MPN, prBST and pdMAmg. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Koumei Takeda: "WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain"Human Molecular Genetics. 10. 477-484 (2001)
Koumei Takeda:“WFS1(沃尔夫拉姆综合征 1)基因产物:培养细胞中内质网的主要亚细胞定位和大鼠脑中的神经元表达”人类分子遗传学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shinoda,K.: "Pre-embedding immuno-electron microscopic in the nervous tissues"Histochemistry and Cytochemistry 2001. 117-122 (2001)
Shinoda,K.:“神经组织中的预嵌入免疫电子显微镜”组织化学和细胞化学 2001. 117-122 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
篠田晃: "神経組織における電子顕微鏡を用いた免疫組織化学-プレエンベッディング法-"組織細胞科学2001. 117-122 (2001)
Akira Shinoda:“在神经组织中使用电子显微镜进行免疫组织化学 - 预嵌入方法 -” Histocytochemistry 2001. 117-122 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Koumei Takeda: "WFS1 (Wolfram syndrome1) gene product : predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain"Human Molecular Genetics. 10・5. 477-484 (2001)
Koumei Takeda:“WFS1(沃尔夫拉姆综合征1)基因产物:培养细胞中内质网的主要亚细胞定位和大鼠脑中的神经表达”人类分子遗传学10・5(2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    Neuroprotection and morphoregulation of centrosome-associated molecules by STB/HAP1 in knock-out or transgenic mice
    • 批准号:
      16H05118
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2016
    • 负责人:
      SHINODA Koh
    • 依托单位:
    Morphological and functional relationship among HAP1, pericentriolar materials and causative factors for neurodegeneration.
    • 批准号:
      25293045
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2013
    • 负责人:
      SHINODA Koh
    • 依托单位:
    A New Hypothesis on Brain Sexual Differentiation and Regulation of Hormone Sensitivity by Local Brain Estrogen-Synthesis
    • 批准号:
      21500326
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2009
    • 负责人:
      SHINODA Koh
    • 依托单位:
    Ultrastructural analysis and molecular screening of the neuronal cytoplasmic inclusion, "the stigmoid body"
    • 批准号:
      17500231
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      2005
    • 负责人:
      SHINODA Koh
    • 依托单位:
    海外基金